Persister mechanisms in Borrelia burgdorferi: implications for improved intervention.
作者信息
Feng Jie, Shi Wanliang, Zhang Shuo, Zhang Ying
出版信息
Emerg Microbes Infect. 2015 Sep 2;4(9):e56. doi: 10.1038/emi.2015.56.
Abstract
摘要
相似文献
1
Persister mechanisms in Borrelia burgdorferi: implications for improved intervention.
Emerg Microbes Infect. 2015 Sep 2;4(9):e56. doi: 10.1038/emi.2015.56.
2
[Polymerase chain reaction in the demonstration of Borrelia burgdorferi DNA].
Hautarzt. 1990 Nov;41(11):587-90.
3
Lyme Borreliosis--the Utility of Improved Real-Time PCR Assay in the Detection of Borrelia burgdorferi Infections.
Adv Clin Exp Med. 2015 Jul-Aug;24(4):663-70. doi: 10.17219/acem/28625.
4
[Borrelia burgdorferi genostrains detected in the Silesian Voivodeship in years 2010-2012].
Przegl Epidemiol. 2012;66(4):587-90.
5
Borrelia burgdorferi sensu stricto and Borrelia afzelii: Population structure and differential pathogenicity.
Int J Med Microbiol. 2015 Oct;305(7):673-81. doi: 10.1016/j.ijmm.2015.08.017. Epub 2015 Aug 21.
6
Higher prevalence of antibodies to Borrelia burgdorferi in psychiatric patients than in healthy subjects.
Am J Psychiatry. 2002 Feb;159(2):297-301. doi: 10.1176/appi.ajp.159.2.297.
7
Prevalence of Borrelia burgdorferi genospecies in Ixodes ricinus ticks from Lublin region (eastern Poland).
Ann Agric Environ Med. 2006;13(2):301-6.
8
Geographical distribution and prevalence of Borrelia burgdorferi genospecies in questing Ixodes ricinus from Romania: a countrywide study.
Ticks Tick Borne Dis. 2013 Sep;4(5):403-8. doi: 10.1016/j.ttbdis.2013.04.007. Epub 2013 Jul 26.
9
[Borrelia burgdorferi infection. I. Aspects of basic research, current approach for diagnosis and therapy].
Hautarzt. 1990 Dec;41(12):648-57.
10
[Using the polymerase chain reaction to Borrelia burgdorferi infection in localized scleroderma injure (morphea), in Venezuelan patients].
Invest Clin. 2010 Sep;51(3):381-90.
引用本文的文献
1
Bacterial persisters: molecular mechanisms and therapeutic development.
Signal Transduct Target Ther. 2024 Jul 17;9(1):174. doi: 10.1038/s41392-024-01866-5.
2
Comparison of the Efficacy of Longer versus Shorter Pulsed High Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome with Bartonellosis and Associated Coinfections.
Microorganisms. 2023 Sep 12;11(9):2301. doi: 10.3390/microorganisms11092301.
3
Lyme disease and the pursuit of a clinical cure.
Front Med (Lausanne). 2023 May 24;10:1183344. doi: 10.3389/fmed.2023.1183344. eCollection 2023.
4
Borrelia burgdorferi, the Lyme disease spirochete, possesses genetically-encoded responses to doxycycline, but not to amoxicillin.
PLoS One. 2022 Sep 30;17(9):e0274125. doi: 10.1371/journal.pone.0274125. eCollection 2022.
5
Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review.
Antibiotics (Basel). 2022 Jul 7;11(7):912. doi: 10.3390/antibiotics11070912.
6
Efficacy of Double-Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-infections: A Report of Three Cases and Retrospective Chart Review.
Antibiotics (Basel). 2020 Oct 22;9(11):725. doi: 10.3390/antibiotics9110725.
7
Evaluation of Disulfiram Drug Combinations and Identification of Other More Effective Combinations against Stationary Phase .
Antibiotics (Basel). 2020 Aug 26;9(9):542. doi: 10.3390/antibiotics9090542.
8
Murine Skin Model for Biofilm.
Antibiotics (Basel). 2020 Aug 19;9(9):528. doi: 10.3390/antibiotics9090528.
9
A Practical Approach to the Diagnosis of Lyme Borreliosis: From Clinical Heterogeneity to Laboratory Methods.
Front Med (Lausanne). 2020 Jul 23;7:265. doi: 10.3389/fmed.2020.00265. eCollection 2020.
10
Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31.
Sci Rep. 2020 Mar 2;10(1):3798. doi: 10.1038/s41598-020-59600-4.
Zotero 插件